Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HealthEquity, Inc. - Common Stock (NQ: HQY )

94.95 +0.19 (+0.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,122,520
Open 93.21
Bid (Size) 95.05 (2)
Ask (Size) 96.40 (1)
Prev. Close 94.76
Today's Range 92.02 - 95.58
52wk Range 64.61 - 105.82
Shares Outstanding 83,389,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Yext, Oracle, Huize Holding And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
+43.49%
+43.49%
1 Month
-9.27%
-9.27%
3 Month
+19.89%
+19.89%
6 Month
+14.78%
+14.78%
1 Year
+44.28%
+44.28%

More News

Read More
Insights into HealthEquity Q3 Earnings
Via Benzinga
Earnings Breakdown: HealthEquity Q3
Via Benzinga
HealthEquity Earnings Analysis: Q3 Recap
Via Benzinga
Earnings Summary: HealthEquity Q3
Via Benzinga
HealthEquity Q3 Earnings Assessment
Via Benzinga
HealthEquity Earnings Report: Q3 Overview
Via Benzinga
NASDAQ:HQY—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via Chartmill
Earnings Scheduled For December 9, 2024
Via Benzinga
Insights into HealthEquity's Upcoming Earnings
Via Benzinga
Expert Ratings For HealthEquity
Via Benzinga
Netflix To Rally More Than 7%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why NASDAQ:HQY Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
In-Depth Examination Of 8 Analyst Recommendations For HealthEquity
Via Benzinga
Why NASDAQ:HQY Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years
Via Benzinga
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Via Benzinga
Topics Government
Exposures Political
Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
Via MarketBeat
Topics Bonds ETFs Economy
Exposures Debt Markets Economy Political
How Will HealthEquity, Other Medtechs Do Under Harris Or Trump Administration?
Via Investor's Business Daily
Topics Government
Exposures Political
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Navigating 8 Analyst Ratings For HealthEquity
Via Benzinga
NASDAQ:HQY qualifies as a high growth stock and is consolidating.
Via Chartmill
Buckle Up And Use Volitility To Your Advantage
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.